Primary Record
letrozole
- In stock
- 2,024 g
- Purity
- 99.7 %
- CAS
- 112809-51-5
Compound Identifiers & Properties
- CAS
- 112809-51-5
- PubChem CID
- 3902
- SMILES
- C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
- Canonical SMILES
- N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1
Names & Synonyms
- letrozole
- Femara
- Letrozol
- 112809-51-5
- piroxicam
- Letoval
- letrozolum
- Femera
- 4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile
- Letrozole?
- Letrozole CRS
- Letrozole-d4
- Letrozole Tablets
- Femara (TN)
- Femara, Letrozole
- CGS 20267
- LETRAZOLE
- CGS-20267
- Letrozole [USAN:INN]
- LEROZOLE
- LETZ
- Letrozole (Standard)
- Letrozole-d4 (major)
- C17H11N5
- LETROZOLE 1G
- LETROZOLE [INN]
- LETROZOLE [JAN]
- RefChem:55460
- DTXSID4023202
- LETROZOLE [MI]
- AC1L1GYT
- LETROZOLE [HSDB]
- LETROZOLE [USAN]
- Prestwick0_001025
- Prestwick1_001025
- Prestwick2_001025
- Prestwick3_001025
- 7LKK855W8I
- CHEMBL1444
- Letrozole (JAN/USP/INN)
- UNII-7LKK855W8I
- HPJKCIUCZWXJDR-UHFFFAOYSA-N
- Femara (TN) (Novartis)
- D0C1WH
- LETROZOLE [MART.]
- CGS20267
- HSDB 7461
- LETROZOLE [USP-RS]
- LETROZOLE [WHO-DD]
- Novartis Brand of Letrozole
- SCHEMBL4331
- CCRIS 8822
- CHEBI:6413
- DTXCID503202
- BIDD:PXR0130
- BSPBio_001209
- MLS000759455
- MLS001424038
- MLS002584991
- MLS006010040
- BIDD:GT0015
- NSC-759652
- FEM-345
- Letrozole - Bio-X trade mark
- SPBio_003070
- Letrozole [USAN:USP:INN:BAN]
- BPBio1_001331
- GTPL5209
- orb1308084
- LETROZOLE [EP IMPURITY]
- LETROZOLE [ORANGE BOOK]
- LETROZOLE [EP MONOGRAPH]
- Letrozole, >=98% (HPLC)
- BDBM13061
- CTK8B5413
- CID3902
- EX-A965
- L02BG04
- LETROZOLE [USP MONOGRAPH]
- QCR-225
- Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-
- MFCD00866241
- NSC719345
- GLXC-05072
- HMS1571M11
- HMS2051E08
- HMS2089L22
- HMS2098M11
- HMS2233C23
- HMS3369E11
- HMS3393E08
- HMS3651K05
- HMS3715M11
- HMS5079O19
- Pharmakon1600-01502354
- 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile
- 4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile
- 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile
- AMY32541
- BCP23354
- CGS-20267 pound>>LETROZOLE
- CID:3902
- IVB71296
- KS-00000XA8
- MSK10362
- ZINC3778874
- Tox21_110719
- Tox21_303572
- 1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole
- ABP001083
- ANW-48664
- CL0020
- EBC-04408
- HY-14248R
- NCGC00016973-01
- NSC759652
- s1235
- STL451047
- 4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile
- AKOS005145822
- AB07525
- AC-1193
- ACN-032052
- AN-6525
- BCP9000848
- C17-H11-N5
- CCG-100849
- CS-1776
- DB01006
- FL24873
- KS-1269
- NC00099
- NSC 759652
- NSC-719345
- RP29922
- RTC-070977
- CAS-112809-51-5
- NCGC00016973-02
- NCGC00016973-03
- NCGC00016973-06
- NCGC00257460-01
- 4CA-0737
- AJ-45577
- BC205693
- BL164620
- BR-59607
- CPD000466343
- H020
- HY-14248
- LS-38788
- SAM001246649
- SC-00402
- SMR000466343
- BCP0726000213
- SID:376229657
- 4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile
- 4-[(4-CYANOPHENYL)(1H-1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE
- AB0012832
- AB1009309
- CGS 20267, Femara, Piroxicam, Letrozole
- J390.644B
- ST2405214
- TL8000371
- 1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole
- 1-Bis(4-cyanophenyl)methyl-1,2,4-triazole
- 4,2,4-Triazol-1-ylmethylene)dibenzonitrile
- AB00514009
- KISQALI FEMARA CO-PACK COMPONENT LETROZOLE
- L0248
- NS00000663
- SW197294-4
- 4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile
- A10523
- A25380
- C08163
- D00964
- EN300-264820
- J10423
- S-4137
- 4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)
- AB00514009-05
- AB00514009-07
- AB00514009-08
- AB00514009-09
- AB00514009_10
- AB00514009_11
- 809L515
- C067431
- F036495
- Letrozole =98.0% (by HPLC, titration analysis)
- Q194974
- SR-01000759382
- W-60273
- 4,4'-(1,2,4-Triazol-1-ylmethylene)dibenzonitrile
- I06-0022
- Q-201291
- SR-01000759382-4
- SR-01000759382-5
- 4,4'-(1H-1,2,4triazol-1-ylmethylene)dibenzonitrile
- BRD-K88789588-001-03-2
- BRD-K88789588-001-14-9
- 4,4 -(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile
- D000077289
- F2173-0288
- Z1741968261
- 4,4 -(1H-1,2,4-Triazole-1-ylmethylene)bisbenzonitrile
- 4,4'-((1H-1,2,4-Triazol-1-yl)-methylene)dibenzonitrile
- 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-Benzonitrile Letrozole
- 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bis[benzonitrile]
- 4,4'-[(1H-1,2,4-Triazol-1-yl)methylene]dibenzonitrile
- Letrozole, European Pharmacopoeia (EP) Reference Standard
- 4,4 -[(1H-1,2,4-Triazol-1-yl)methylene]bisbenzonitrile
- 4,4 -[(1H-1,2,4-Triazole-1-yl)methylene]dibenzonitrile
- 4-((4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl)benzonitrile
- Letrozole, United States Pharmacopeia (USP) Reference Standard
- 4-((4-cyanophenyl)(1H-1,2,4-triazol-1-yl)methyl)benzonitrile
- TRANS-1-(4-BUTYL-CYCLOHEXYL)-4-ETHOXY-2,3-DIFLUORO-BENZENE
- 1133712-96-5
- 4-[1-(4-CYANOPHENYL)-1-(1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE
- Letrozole, Pharmaceutical Secondary Standard; Certified Reference Material
- 4,4 inverted exclamation marka-(1H-1,2,4-Triazol-1-ylmethylene)bisbenzonitrile
- 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]-2,3,5,6-tetradeuteriobenzonitrile
- 675-034-8
- CGS 20267; Femara; Lerozole; Letrazole; 4,4'-((1H-1,2,4-triazol-1-yl)methylene)dibenzonitrile